Search results for "gastric bypass"

showing 10 items of 30 documents

Laparoscopic gastric banding as a universal method for the treatment of patients with morbid obesity.

2004

Introduction: This study analyzed the influence of potentially negative predictors such as sweet-eating behavior, super-obesity, social and psychological status, family and education situation, intake of sedative drugs, and the distance between hospital and home on the outcome of laparoscopic adjustable gastric banding (LAGB). Methods: 77 women and 29 men with mean age 40.6 years (28-47) underwent LAGB. Preoperative mean body weight was 146 kg (99-179), and mean BMI was 48.1 kg/m 2 (36.4-73.5). The influence of the above-mentioned potentially negative predictors on weight loss was the primary end point. Results: Mean follow-up was 44.6 ′ 19.7 months. Follow-up was possible in all but 6 pati…

AdultMalemedicine.medical_specialtyGastroplastyGastric bandingmedicine.drug_classEndocrinology Diabetes and MetabolismGastric bypassMorbid obesityWeight lossmedicineClinical endpointHumansUnivariate analysisNutrition and Dieteticsbusiness.industryPatient SelectionMiddle AgedSurgeryObesity MorbidTreatment OutcomeSedativeSurgeryFemaleLaparoscopymedicine.symptombusinessLaparoscopic adjustable gastric bandingObesity surgery
researchProduct

Abdominal pain and internal hernias after Roux-en-Y Gastric Bypass: are we dealing with the tip of an iceberg?

2019

Background: Abdominal pain is the most frequent cause of hospital admission after Roux-en-y gastric bypass (RYGB). Among numerous possible underlying causes, internal hernias represent one of the most peculiar and insidious conditions, setting challenging diagnostic and therapeutic problems for the surgeon. The aim of this study is to analyze aspecific abdominal pain incidence and characteristics after RYGB, discriminating peculiar aspects suggestive of internal hernias. Methods: 13 patients submitted to internal hernia repair after laparoscopic antecolic RYGB and a group of 49 controls (non-complicated RYGB) have been assessed using a specific questionnaire. Overall aspecific abdominal pai…

AdultMaleobesityIncidenceabdominal painGastric Bypassnutritional and metabolic diseasesMiddle Agedinternal herniaRisk AssessmentHernia AbdominalObesity MorbidBody Mass IndexHospitals UniversityPeteresen herniaPostoperative ComplicationsItalyCase-Control StudiesSurveys and QuestionnairesHumansOriginal ArticleFemaleLaparoscopyHerniorrhaphyFollow-Up StudiesActa Bio Medica : Atenei Parmensis
researchProduct

The treatment of hyperinsulinemic hypoglycaemia in adults: an update

2016

Treatment of hyperinsulinemic hypoglycaemia (HH) is challenging due to the rarity of this condition and the difficulty of differential diagnosis. The aim of this article is to give an overview of the recent literature on the management of adult HH. A search for reviews, original articles, original case reports between 1995 and 2016 in PubMed using the following keywords: hyperinsulinemic hypoglycaemia, insulinoma, nesidioblastosis, gastric bypass, autoimmune hypoglycaemia, hyperinsulinism, treatment was performed. One hundred and forty articles were selected and analysed focusing on the most recent treatments of HH. New approaches to treatment of HH are available including mini-invasive sur…

Adultmedicine.medical_specialtyPediatricsendocrine system diseasesEndocrinology Diabetes and MetabolismGastric bypassNesidioblastosis030209 endocrinology & metabolismHypoglycemiaSettore MED/13 - Endocrinologia03 medical and health sciences0302 clinical medicineEndocrinologyHyperinsulinismmedicineHyperinsulinemic hypoglycaemiaHumansAutoimmune hypoglycaemiaInsulinomaEverolimusbusiness.industryAutoimmune hypoglycaemia; Hyperinsulinemic hypoglycaemia; Insulinoma; Nesidioblastosis; Treatment; Adult; Humans; Hyperinsulinism; HypoglycemiaAutoimmune hypoglycaemia; Hyperinsulinemic hypoglycaemia; Insulinoma; Nesidioblastosis; Treatment; Adult; Humans; Hyperinsulinism; Hypoglycemia; Endocrinology Diabetes and Metabolism; EndocrinologySettore MED/13 - ENDOCRINOLOGIANesidioblastosimedicine.diseaseHypoglycemiaSurgeryDiabetes and MetabolismTreatmentNesidioblastosisAutoimmune hypoglycaemia; Hyperinsulinemic hypoglycaemia; Insulinoma; Nesidioblastosis; Treatment030220 oncology & carcinogenesisAutoimmune hypoglycaemiaInsulinomaAutoimmune hypoglycaemia; Hyperinsulinemic hypoglycaemia; Insulinoma; Nesidioblastosis; Treatment; Endocrinology Diabetes and Metabolism; EndocrinologyDifferential diagnosisbusinessHyperinsulinismhormones hormone substitutes and hormone antagonistsmedicine.drugHuman
researchProduct

Surgery for obesity.

2005

PURPOSE OF REVIEW Bariatric surgery today is the only effective therapy for morbid obesity. Commonly performed procedures include adjustable gastric banding and vertical banded gastroplasty, variations of the Roux-en-Y gastric bypass, biliopancreatic diversion or duodenal switch, and mixed procedures. This review discusses key issues in the surgical management of morbid obesity. RECENT FINDINGS The two most common bariatric procedures performed worldwide are laparoscopic adjustable gastric banding and laparoscopic Roux-en-Y gastric bypass. Controversy exists regarding the best surgical procedure. Weight loss decreases according to the procedures performed in following decreasing order: bili…

Cultural Studiesmedicine.medical_specialtyGastroplastyCost effectivenessbusiness.industrymedicine.medical_treatmentCost-Benefit AnalysisGastric BypassBariatric SurgeryPerioperativemedicine.diseaseObesityDuodenal switchEducationSurgeryMorbid obesityQuality of lifeWeight lossmedicineHumansmedicine.symptombusinessBiliopancreatic DiversionCurrent opinion in gastroenterology
researchProduct

BALLOON-OVERTUBE ENTEROSCOPY ASSISTED (BAE) VERSUS LAPAROSCOPY-ASSISTED ERCP IN BARIATRIC POST- ROUX-EN-Y GASTRIC BYPASS PATIENTS: A COMPARATIVE STUDY

2018

Enteroscopymedicine.medical_specialtymedicine.diagnostic_testbusiness.industryGastric bypassmedicineLaparoscopyBalloonbusinessRoux-en-Y anastomosisSurgeryESGE Days 2018 accepted abstracts
researchProduct

Obesidad Infantil. Recomendaciones del Comité de Nutrición de la Asociación Española de Pediatría. Parte II. Diagnóstico. Comorbilidades. Tratamiento

2007

En el presente artículo se revisan los criterios actuales para el diagnóstico de la obesidad y de sus comorbilidades en la edad pediátrica, así como el tratamiento en todas sus vertientes: dietético, ejercicio físico, farmacológico y quirúrgico. : The present article reviews the diagnostic criteria for pediatric obesity and its comorbidities. Treatment is also reviewed, including promotion of physical activity, and dietetic, pharmacologic and surgical treatment.

Gynecologymedicine.medical_specialtyPhysical activitybusiness.industryGastric bypassPhysical activityPediatric obesityNutritional statusDietetic treatmentPediatricsPharmacologic treatmentRJ1-570ComorbiditiesSurgeryTratamiento farmacologicoDiagnosisPediatrics Perinatology and Child HealthAppetite depressantsmedicinebusinessSurgical treatmentAnales de Pediatría
researchProduct

Impaired oral absorption of methylphenidate after Roux-en-Y gastric bypass

2017

The anatomic and physiologic changes in the gastrointestinal (GI) tract after bariatric surgery may significantly affect the pharmacokinetics of medications taken by the patients for various reasons. Unfortunately, there is little information regarding changes in drug absorption after bariatric surgeries, limiting the ability of medical professionals to produce clear recommendations on what changes should be made to the formulations and dosing regimens of drugs after bariatric surgery. In this article, we report and analyze a case of 52-year-old male patient with morbid obesity and attention-deficit/hyperactivity disorder (ADHD) who experienced lack of methylphenidate efficacy after Roux en…

MaleDrugmedicine.medical_specialtyTransdermal patchmedia_common.quotation_subjectGastric BypassAdministration Oral03 medical and health sciences0302 clinical medicinePharmacokinetics0502 economics and businessmedicineHumans030212 general & internal medicineDosingmedia_commonMethylphenidatebusiness.industry05 social sciencesMiddle Agedmedicine.diseaseObesityRoux-en-Y anastomosisObesity MorbidSurgeryAttention Deficit Disorder with HyperactivityGastrointestinal AbsorptionAnesthesiaToxicityMethylphenidateCentral Nervous System Stimulants050211 marketingSurgerybusinessmedicine.drugSurgery for Obesity and Related Diseases
researchProduct

Vertical Banded Gastroplasty Converted to Roux-en-Y Gastric Bypass: Little Impact on Nutritional Status after 5-Year Follow-up

2004

Background: Conversion to a Roux-en-Y gastric bypass (RYGBP) has been advocated after the failure of vertical banded gastroplasty (VBG). The aim of this study was to analyze the differences in anthropometric and nutritional parameters between patients with VBG and those converted to RYGBP. Methods: 45 patients initially underwent VBG. 22 of these patients have maintained this operation for more than 5 years (Group A) and 23 have been converted to RYGBP (Group B), after 2 years of follow-up. We analyzed anthropometric and nutritional parameters (macronutrients,micronutrients and lipid profile), and postoperative morbidity after both procedures. Data were recorded before the first operation a…

Malemedicine.medical_specialtyGastroplastyEndocrinology Diabetes and MetabolismGastric BypassNutritional StatusWeight LossHumansMedicinePostoperative PeriodTreatment FailureVitamin B12Nutrition and Dieteticsmedicine.diagnostic_testbusiness.industryMortality rateTransferrinNutritional statusAnthropometryMicronutrientRoux-en-Y anastomosisSurgeryBanded gastroplastyVitamin B 12FemaleSurgerybusinessLipid profileFollow-Up StudiesObesity Surgery
researchProduct

Single-centre, triple-blinded, randomised, 1-year, parallel-group, superiority study to compare the effects of Roux-en-Y gastric bypass and sleeve ga…

2019

IntroductionBariatric surgery is increasingly recognised as an effective treatment option for subjects with type 2 diabetes and obesity; however, there is no conclusive evidence on the superiority of Roux-en-Y gastric bypass or sleeve gastrectomy. The Oseberg study was designed to compare the effects of gastric bypass and sleeve gastrectomy on remission of type 2 diabetes and β-cell function.Methods and analysisSingle-centre, randomised, triple-blinded, two-armed superiority trial carried out at the Morbid Obesity Centre at Vestfold Hospital Trust in Norway. Eligible patients with type 2 diabetes and obesity were randomly allocated in a 1:1 ratio to either gastric bypass or sleeve gastrecto…

Malemedicine.medical_specialtySleeve gastrectomyβ-cell functionmedicine.medical_treatment1843Gastric BypassBariatric Surgery030209 endocrinology & metabolismType 2 diabeteslaw.invention03 medical and health sciences0302 clinical medicineSuperiority TrialRandomized controlled trialClinical ProtocolslawGastrectomyDiabetes mellitusInternal medicineInsulin-Secreting CellsmedicineProtocolHumans030212 general & internal medicine1506VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Kardiologi: 771Glycated Hemoglobinbusiness.industryNorwayGeneral Medicinemedicine.diseaseRoux-en-Y anastomosismorbid obesityObesity MorbidDiabetes and EndocrinologyTreatment OutcomeDiabetes Mellitus Type 2GastrectomyFemaleLaparoscopytype 2 diabetesbusinessEpidemiologic MethodsBody mass indexrandomised controlled trialsleeve gastrectomy
researchProduct

Impact of body weight, low energy diet and gastric bypass on drug bioavailability, cardiovascular risk factors and metabolic biomarkers: protocol for…

2018

IntroductionRoux-en-Y gastric bypass (GBP) is associated with changes in cardiometabolic risk factors and bioavailability of drugs, but whether these changes are induced by calorie restriction, the weight loss or surgery per se, remains uncertain. The COCKTAIL study was designed to disentangle the short-term (6 weeks) metabolic and pharmacokinetic effects of GBP and a very low energy diet (VLED) by inducing a similar weight loss in the two groups.Methods and analysisThis open, non-randomised, three-armed, single-centre study is performed at a tertiary care centre in Norway. It aims to compare the short-term (6 weeks) and long-term (2 years) effects of GBP and VLED on, first, bioavailability…

OncologyMale030226 pharmacology & pharmacylaw.inventionTertiary Care Centers0302 clinical medicineWeight losslawRisk FactorsProtocol1506Omeprazolemedia_commonClinical Trials as TopicClinical pharmacologyNorwayArea under the curveGeneral MedicineObesity MorbidPharmaceutical PreparationsCardiovascular DiseasescardiologyBody CompositionFemalemedicine.symptommedicine.drugDrugmedicine.medical_specialtymedia_common.quotation_subjectGastric Bypassbasic sciencesBiological Availability030209 endocrinology & metabolism03 medical and health sciencesPharmacokineticsInternal medicineWeight LossmedicineHumansRosuvastatinPharmacokinetics1723Caloric Restrictionbusiness.industryPharmacology and TherapeuticsBioavailabilityLinear Modelsclinical pharmacologybusinessBiomarkers
researchProduct